Biotechnology News and Research

RSS

Nuclera launches GPCR-focused nanodisc panel to streamline membrane protein production

Nuclera, the biotechnology company enabling rapid access to high-quality proteins, today announced the launch of its nanodisc panel to support screening and scale-up of G-Protein Coupled Receptors (GPCRs).

From Nuclera 30 Mar 2026

CDC tracks SARS-CoV-2 BA.3.2 global rise and finds early signals in U.S. wastewater

CDC surveillance shows that the highly divergent SARS-CoV-2 variant BA.3.2 spread to at least 23 countries and was detected in U.S. travelers, patients, airplane wastewater, and wastewater samples across multiple states. The report highlights wastewater and traveler-based genomic surveillance as early warning tools while noting that BA.3.2 has immune-evasion potential but has not rapidly displaced other circulating lineages.

25 Mar 2026

Insilico and ASKA partner to advance AI-driven gynecological drug discovery

Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial intelligence (AI), today announced a strategic research collaboration with ASKA Pharmaceutical Co., Ltd. ("ASKA"), a specialized pharmaceutical company with a strong focus on internal medicine, obstetrics, and gynecology.

24 Mar 2026

Lab-grown food pipe offers hope for children with esophageal conditions

Scientists from Great Ormond Street Hospital (GOSH) and University College London (UCL) have created the first lab‑grown esophagus - the food pipe - shown to safely replace a full section of the organ and restore normal function, including swallowing, in a growing animal without the need for immunosuppression.

23 Mar 2026

Study identifies protein that slows cartilage breakdown in joints

Osteoarthritis, a condition that causes pain and reduced mobility in joints such as the knees and fingers, is one of the most common joint disorders worldwide, particularly among aging populations.

23 Mar 2026

Scientists identify new target to slow Huntington’s disease progression

Huntington's disease is a devastating brain disorder that slowly robs people of movement, memory and personality.

23 Mar 2026

New approach tracks metabolic fingerprints of tuberculosis-infected human cells

Researchers from King's College London and the University of Surrey have developed a new technique to measure the content of individual human cells infected with bacteria that model tuberculosis – and it is already revealing biological changes that conventional analysis would miss.

18 Mar 2026

ProImmune and the Roslin Institute collaborate to advance animal health science

ProImmune Ltd, a global leader in immunological reagents and services, today announced a collaboration with the University of Edinburgh's Roslin Institute to advance veterinary immunology research through development and validation of novel species-specific Ankyron® binders.

From ProImmune Ltd. 18 Mar 2026

New approach developed to visualize proteins at unprecedented scale and sensitivity

Proteins, one of the smallest building blocks of life on Earth, hold promise for answering some of biology's biggest questions.

18 Mar 2026

DNA Script expands global access to on-demand DNA synthesis with distributor agreements in Latin America and East Asia

DNA Script, a pioneer in DNA synthesis providing scientists with rapid, on-demand access to high-quality DNA, today announced it has signed distribution agreements with Gencell, Bio-Medical Science Co. (BMS), and BioStream Co., expanding global access to the Company's SYNTAX® platform for decentralized, in-house and on-demand oligonucleotide production.

From DNA Script 18 Mar 2026

Study reveals dual role of PFK enzyme in metabolism and cell cycle progression

A metabolic enzyme studied for over seven decades has a hidden second function - it can unwind RNA and promote cell cycle progression, an additional function beyond its role in energy production, according to a new study led by the University of Surrey.

16 Mar 2026

Defining the limits of immunotherapy in early small-cell lung cancer

Immunotherapy given during and after chemoradiation did not improve survival for study participants with limited-stage, small-cell lung cancer (SCLC) according to the results of an international clinical trial, NRG-LU005, led by NRG Oncology in collaboration with the Alliance for Clinical Trials in Oncology. The results are published in the Journal of Clinical Oncology.

13 Mar 2026

UVA researcher receives $3.4 million grant to improve weight-management programs

A University of Virginia School of Medicine researcher has received $3.4 million from the National Institutes of Health to increase the availability of weight-management programs that offer beneficial personalized feedback.

12 Mar 2026

Study links prior authorization to delayed heart failure prescriptions

Prior authorization, a process that requires physicians to obtain approval from health care insurers before certain treatments are covered, may keep patients from filling prescriptions for two critical heart failure drugs, a new study shows.

12 Mar 2026

iXCells Biotechnologies reaches iPSC line delivery milestone in collaboration with global biotechnology company

iXCells Biotechnologies USA, Inc. ("iXCells"), a leading provider of human cell-based solutions and custom iPSC services, today announced the delivery of over 500 characterized induced pluripotent stem cell (iPSC) lines as part of a multi-year collaboration with a global biotechnology company.

From iXCells Biotechnologies 12 Mar 2026

Simplified nanoparticles "educate" the immune system to find and destroy disease-causing cells

Johns Hopkins Medicine scientists say they have developed a simplified version of biodegradable nanoparticles that can "educate" the immune system to find and destroy disease-causing cells throughout the body.

11 Mar 2026

Severe COVID and flu infections increase risk of lung cancer

Severe COVID-19 and influenza infections prime the lungs for cancer and can accelerate the disease's development, but vaccination heads off those harmful effects, new research from UVA Health's Beirne B. Carter Center for Immunology Research and UVA Comprehensive Cancer Center indicates.

11 Mar 2026

DNA-based barcoding reveals which nanoparticles successfully deliver genetic therapies

Drug delivery researchers have vastly improved the potential of genetic therapies by overcoming the challenge of consistently getting genes and gene-editing tools where they need to be within cells.

11 Mar 2026

Rapid Novor receives Ontario Ministry of Health provisional license for EasyM® blood-based MRD test for multiple myeloma

Rapid Novor Inc., a Canadian biotechnology leader, announced today that its diagnostic laboratory has received a provisional license from the Ontario Ministry of Health (MOH) for its EasyM® assay, enabling the company to begin testing patients in Canada.

From Rapid Novor Inc 11 Mar 2026

Researchers develop DNA aptamer to detect Alzheimer's biomarkers

With aging populations on the rise, the need for better tools to diagnose and monitor Alzheimer's disease (AD), the most common cause of dementia, has never been more urgent.

10 Mar 2026

Biotechnology News and Research

Nuclera launches GPCR-focused nanodisc panel to streamline membrane protein production

CDC tracks SARS-CoV-2 BA.3.2 global rise and finds early signals in U.S. wastewater

Insilico and ASKA partner to advance AI-driven gynecological drug discovery

Lab-grown food pipe offers hope for children with esophageal conditions

Study identifies protein that slows cartilage breakdown in joints

Scientists identify new target to slow Huntington’s disease progression

New approach tracks metabolic fingerprints of tuberculosis-infected human cells

ProImmune and the Roslin Institute collaborate to advance animal health science

New approach developed to visualize proteins at unprecedented scale and sensitivity

DNA Script expands global access to on-demand DNA synthesis with distributor agreements in Latin America and East Asia

Study reveals dual role of PFK enzyme in metabolism and cell cycle progression

Defining the limits of immunotherapy in early small-cell lung cancer

UVA researcher receives $3.4 million grant to improve weight-management programs

Study links prior authorization to delayed heart failure prescriptions

iXCells Biotechnologies reaches iPSC line delivery milestone in collaboration with global biotechnology company

Simplified nanoparticles "educate" the immune system to find and destroy disease-causing cells

Severe COVID and flu infections increase risk of lung cancer

DNA-based barcoding reveals which nanoparticles successfully deliver genetic therapies

Rapid Novor receives Ontario Ministry of Health provisional license for EasyM® blood-based MRD test for multiple myeloma

Researchers develop DNA aptamer to detect Alzheimer's biomarkers

Event guide: 3rd IMPACCT Real World Evidence Summit Europe eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News